Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IMDRF Issues Proposed Guidances On Device Auditors, Global UDI System

This article was originally published in The Gray Sheet

Executive Summary

The International Medical Device Regulators Forum issued proposed guidance documents on monitoring of device auditing organizations, training for auditors and core elements of a global UDI system.

You may also be interested in...



FDA, Global Partners Prepare To Ramp Up Single-Audit Program

FDA is strongly encouraging manufacturers to participate in the Medical Device Single Audit Program, set to launch in a pilot phase by June. An agency official points to strong global incentives, particularly for firms pursuing the Brazil and Canada markets.

Single-Audit, UDI And Software International Harmonization Docs Finalized

The International Medical Device Regulators Forum issued four final guidance documents on an upcoming pilot that will allow companies to satisfy inspection requirements for four countries in one inspection, and separate documents on a global unique device identification program and standalone software.

Industry Sees Harmonization Opportunities In High-level U.S.-EU Trade Talks

Official negotiations between the U.S. and EU on the Transatlantic Trade and Investment Partnership trade agreement began last week. Medical device industry associations representing both regions want the harmonization of U.S. and EU device industry regulations to be part of the agreement.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel